Matthew L. Posard - Nov 30, 2021 Form 4 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role
Director
Signature
/s/ Matthew B. Murphy, as Attorney-in-Fact
Stock symbol
NAUT
Transactions as of
Nov 30, 2021
Transactions value $
$225,505
Form type
4
Date filed
12/1/2021, 08:41 PM
Previous filing
Jun 9, 2021
Next filing
May 6, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAUT Common Stock Purchase $91.4K +20K $4.57 20K Nov 30, 2021 Direct
transaction NAUT Common Stock Purchase $45K +10K +50% $4.50 30K Dec 1, 2021 Direct
transaction NAUT Common Stock Purchase $44.6K +10K +33.33% $4.46 40K Dec 1, 2021 Direct
transaction NAUT Common Stock Purchase $44.5K +10K +25% $4.45 50K Dec 1, 2021 Direct
holding NAUT Common Stock 100K Nov 30, 2021 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by the Matthew and Elizabeth Posard Trust. The reporting person is the Trustee of the Matthew and Elizabeth Posard Trust.